Hyperkalemia after endobiliary radiofrequency ablation for malignant biliary obstruction

2021 ◽  
Author(s):  
Tadahisa Inoue ◽  
Rena Kitano ◽  
Masashi Yoneda
Keyword(s):  
Radiofrequency Ablation ◽  
Biliary Obstruction ◽  
Malignant Biliary Obstruction

scholarly journals Endoscopic radiofrequency ablation for malignant biliary obstruction

2021 ◽  
Vol 13 (10) ◽  
pp. 1383-1396
Author(s):  
Jana Jarosova ◽  
Peter Macinga ◽  
Alzbeta Hujova ◽  
Jan Kral ◽  
Ondrej Urban ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Biliary Obstruction ◽  
Malignant Biliary Obstruction ◽  
Endoscopic Radiofrequency Ablation

Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction

2020 ◽  
Vol 45 (11) ◽  
pp. 3690-3697 ◽  
Author(s):  
Tianzhu Yu ◽  
Wei Zhang ◽  
Changyu Li ◽  
Chenggang Wang ◽  
Gaoquan Gong ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Stent Placement ◽  
Biliary Obstruction ◽  
Malignant Biliary Obstruction ◽  
Biliary Stent

Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction

2011 ◽  
Vol 73 (1) ◽  
pp. 149-153 ◽  
Author(s):  
Alan W. Steel ◽  
Aymer J. Postgate ◽  
Shirin Khorsandi ◽  
Joanna Nicholls ◽  
Long Jiao ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Biliary Obstruction ◽  
Malignant Biliary Obstruction

PWE-015 Radiofrequency ablation for management of malignant biliary obstruction

Gut ◽  
2015 ◽  
Vol 64 (Suppl 1) ◽  
pp. A216.2-A217
Author(s):  
AK Dutta ◽  
U Basavaraju ◽  
L Sales ◽  
JS Leeds
Keyword(s):  
Radiofrequency Ablation ◽  
Biliary Obstruction ◽  
Malignant Biliary Obstruction

scholarly journals Radiofrequency Ablation Combined with Stent Placement versus Stent Placement Alone for Malignant Biliary Obstruction: A Systematic Review and Meta-analysis

2020 ◽  
Author(s):  
Hongyang Chen ◽  
Chunxian Zhu ◽  
Leimin Sun
Keyword(s):  
Radiofrequency Ablation ◽  
Stent Placement ◽  
Biliary Obstruction ◽  
Meta Analysis ◽  
Malignant Biliary Obstruction ◽  
Hazard Ratio ◽  
Mean Difference ◽  
Controlled Trials ◽  
Kaplan Meier ◽  
The Mean

Abstract Background: Malignant biliary obstruction was typically diagnosed at an advanced stage due to painless jaundice. Stent placement is the therapy of choice in this set of patients. Radiofrequency ablation is an ablative therapy which has been well recognized for treating malignant biliary strictures. This meta-analysis aims to help to better understand the safety and efficacy of biliary Radiofrequency ablation combined with stent placement. Methods: Five databases (PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and China National Knowledge Infrastructure) were searched for randomized controlled trials and observational studies up to April 2020. Results: The mean difference in survival time was 54.87 days (95% confidence interval CI, 34.6-75.14), meaning patients performed with radiofrequency ablation benefit more. Reconstructed Kaplan-Meier data showed improved survival in joint intervention with RFA (hazard ratio, 1.39; 95%CI, 1.34-1.75; P < .001). However, no survival benefit was observed in the extrahepatic distal cholangiocarcinoma. With regard to patency time, the mean difference was 42.88 days (95%CI, 34.02-51.37). Reconstructed Kaplan-Meier data showed improved survival in the radiofrequency ablation treated group (hazard ratio, 1.629; 95%CI, 1.35-1.96; P < .001). Concerning postoperative complications such as abdominal pain, cholangitis and pancreatitis, our analysis did not show a significant difference between the radiofrequency ablation treatment group and the controls. Conclusion: Radiofrequency ablation plus stent resulted in improved survival and stent patency, with longer median survival and patency time than stent alone.

Sign in / Sign up

Export Citation Format

Share Document